Transcutaneous Bilirubinometry in Neonates With the Bilicare System
Transcutaneous Bilirubinometry in Neonates With the Bilicare System
The purpose of this study is to test the performance of a new transcutaneous ("measured
 through skin") bilirubin device (BiliCare™) to measure bilirubin levels. The investigators
 plan to evaluate the clinical performance of this device as a point of care test. If the
 investigators can validate the BiliCare™ with bilirubin from your baby's blood they could
 verify a non-invasive alternative for measuring bilirubin.
Inclusion Criteria:

 1. Parental informed consent

 2. Male and female newborns with a GA ≥ 35 wks

 3. Enrollment at age > 6 hrs until neonatal discharge

 4. Pre-phototherapy

 Exclusion Criteria:

 1. Infants requiring respiratory assistance (such as mechanical ventilation)

 2. Severe or life-threatening congenital anomalies

 3. Hematomas at the point of measurement on both ears

 4. Neonates undergone blood transfusion